Advanced glycation endproducts are deposited in neuronal hyaline inclusions: A study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation

Acta Neuropathologica

Volumn 97, Issue 3, 1999, Pages 240-246

  Shibata, Noriyuki ^a   Hirano, Asao ^b   Kato, Shinsuke ^c   Nagai, Ryoji ^d   Horiuchi, Seikoh ^d   Komori, Takashi ^e   Umahara, Takahiko ^f   Asayama, Kohtaro ^g   Kobayashi, Makio ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c TOTTORI UNIVERSITY   (Japan)

^d KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^e TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^f TOKYO MEDICAL UNIVERSITY   (Japan)

^g UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Advanced glycation endproducts; Amyotrophic lateral sclerosis; Hyaline inclusions; Immunohistochemistry; Superoxide dismutase

Indexed keywords

ADVANCED GLYCATION END PRODUCT; HYALIN; MONOCLONAL ANTIBODY; NEUROFILAMENT PROTEIN; SUPEROXIDE DISMUTASE; UBIQUITIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL INCLUSION; CODON; CONTROLLED STUDY; CYTOPLASM; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MOTONEURON; OXIDATIVE STRESS; PRIORITY JOURNAL; SPINAL CORD;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODIES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYALIN; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; LYSINE; MALE; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; MOTOR NEURONS; NEUROFILAMENT PROTEINS; SPINAL CORD; SUPEROXIDE DISMUTASE; UBIQUITINS;

EID: 0032980525     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050980     Document Type: Article

References (59)

1. ε-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261:4889-4894
2. Andersen PM, Nilsson P, Ala-Hurula V, Keränen M-L, Tarvainen I, Haltia T, Nilsson L, Binzer M, Forsgren L, Marklund SL (1995) Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet 10:61-65
3. Arai K, Maguchi S, Fujii S, Ishibashi H, Oikawa K, Taniguchi N (1987) Glycation and inactivation of human Cu-Zn-superoxide dismutase. J Biol Chem 262:16969-16972
4. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S (1992) Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 267:10211-10214
5. Asayama K, Janco RL, Burr IM (1985) Selective induction of manganous superoxide dismutase in human monocytes. Am J Physiol 249:C393-C397
6. Beckman JS, Carson M, Smith CD, Koppenol WH (1993) ALS, SOD and peroxynitrite. Nature 364:584
7. Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu Z-S, Wong PC, Brown RH Jr, Price DL, Sisodia SS, Clevelan DW (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 91:8292-8296
8. Carri MT, Battistoni A, Polizio F, Desideri A, Rotilio G (1994) Impaired copper binding by the H46R mutant of human Cu, Zn superoxide dismutase, involved in amyotrophic lateral sclerosis. FEBS Lett 356:314-316
9. 2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett 414:365-368
10. Castellani R, Smith MA, Richey PL, Perry G (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 737:195-200
11. Chou SM, Wang HS, Taniguchi A (1996) Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND. J Neurol Sci 139 [Suppl]:16-26
12. Cudkowicz ME, McKenna-Yasek D, Chen C, Hedley-Whyte ET, Brown RH Jr (1998) Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene. Ann Neurol 43:703-710
13. Deng H-X, Hentati A, Tainer JA, et al (1993) Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide disamutase. Science 261:1047-1051
14. ε-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry 30:1205-1210
15. Durham HD, Roy J, Dong L, Figlewicz DA (1997) Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J Neuropathol Exp Neurol 56:523-530
16. Fridovich I (1986) Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol 58:61-97
17. ε(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 271:9982-9986
18. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng H-X, Chen W, Zhai P, Sufit RL, Siddique T (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772-1775
19. Hayase F, Nagaraj RH, Miyata S, Njoroge FG, Monnier VM (1989) Aging of proteins: immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J Biol Chem 263:3758-3764
20. Hirano A (1996) Neuropathology of ALS: an overview. Neurology 47 [Suppl 2]:S63-S66
21. Hirano A, Kurland LT, Sayre GP (1967) Familial amyotrophic lateral sclerosis: a subgroup characterized by posterior and spino-cerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol 16:232-243
22. Hirano A, Nakano I, Kurland LT, Mulder DW, Holley PW, Saccomanno G (1984) Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 43:471-480
23. Horiuchi S, Araki N, Morino Y (1991) Immunochemical approach to characterize advanced glycation end products of the Maillard reaction: evidence for the presence of a common structure. J Biol Chem 266:7329-7332
24. ε-(Carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35:8075-8083
25. Kato S, Shimoda M, Watanabe Y, Nakashima K, Takahashi K, Ohama E (1996) Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1 gene: multi-system degeneration with intracytoplasmic hyaline inclusions in astrocytes. J Neuropathol Exp Neurol 55:1089-1101
26. Kato T, Hirano A, Kurland LT (1987) Asymmetric involvement of the spinal cord involving both large and small anterior horn cells in a case of familial amyotrophic lateral sclerosis. Clin Neuropathol 6:67-70
27. Kato Y, Tokunaga K, Osawa T (1996) Immunochemical detection of carboxymethylated Apo B-100 in copper-oxidized LDL. Biochem Biophys Res Commun 226:923-927
28. Kimura T, Takamatsu J, Ikeda K, Kondo A, Miyakawa T, Horiuchi S (1996) Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons. Neurosci Lett 208:53-56
29. Kume S, Takeya M, Mori T, Araki N, Suzuki H, Horiuchi S, Komada T, Miyauchi Y, Takahashi K (1995) Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol 147:654-667
30. Kurland LT, Mulder DW (1955) Epidemiologic investigations of amyotrophic lateral sclerosis. 2. Familial aggregations indicative of dominant inheritance. Neurology 5:249-268
31. Ledesma MD, Bonay P, Avila J (1995) T. protein from Alzheimer's disease patients is glycated at its tubulin-binding domain. J Neurochem 65:1658-1664
32. Levanon D, Lieman-Hurwitz J, Dafni N, Wigderson M, Sherman L, Bernstein Y, Laver-Rudich Z, Danciger E, Stein O, Groner Y (1985) Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase. EMBO J 4:77-84
33. Makino H, Shikata K, Hironaka K, Kushiro M, Yamasaki Y, Sugimoto H, Ota Z, Araki N, Horiuchi S (1995) Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy. Kidney Int 48:517-526
34. Miyata T, Oda O, Inagi R, Iida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K, Kinoshita T (1993) β2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92:1243-1252
35. Monnier VM (1989) Toward a Maillard reaction theory of aging. In: Baynes JW, Monnier VM (eds) The Maillard reaction in aging, diabetes, and nutrition. Liss, New York, pp 1-22
36. ε-(carboxymethyl)lysine formation from Amadori product. Biochem Biophys Res Commun 234:167-172
37. Nakamura K, Hasegawa T, Fukunaga Y, Ienaga K (1992) Crosslines A and B as candidates for the fluorophores in age- and diabetes-related cross-linked proteins, and their diacetates produced by Maillard reaction of α-N-acetyl-L-lysine with D-glucose. J Chem Soc Chem Commun 14:992-994
38. Nakano I, Hirano A, Kurland LT, Mulder DW, Holley PW, Saccomanno G (1984) Familial amyotrophic lateral sclerosis: neuropathology of two brothers in American "C" family. Neurol Med (Tokyo) 20:458-471
39. Nakano R, Sato S, Inuzuka T, Sakimura K, Mishina M, Takahashi H, Ikuta F, Honma Y, Fujii J, Taniguchi N, Tsuji S (1994) A novel mutation in Cu/Zn superoxide dismutase gene in Japanese familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 200:695-703
40. Ookawara T, Kawamura N, Kitagawa Y, Taniguchi N (1992) Site-specific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction. J Biol Chem 267:18505-18510
41. Pramatarova A, Goto J, Nanba E, Nakashima K, Takahashi K (1994) A two base-pair deletion in the SOD 1 gene causes familial amyotrophic lateral sclerosis. Hum Mol Genet 3:2061-2062
42. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH Jr, Scott RW, Snider WD (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13:43-47
43. Rechsteiner M (1987) Ubiquitin-mediated pathways for intracellular proteolysis. Annu Rev Cell Biol 3:1-30
44. Rosen DR, Siddique T, Patterson D, et al (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62
45. Sell DR, Monnier VM (1989) Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 264:21597-21602
46. Shibata N, Hirano A, Kobayashi M, Asayama K, Umahara T, Komori T, Ikemoto A (1993) Immunohistochemical demonstration of Cu/Zn superoxide dismutase in the spinal cord of patients with familial amyotrophic lateral sclerosis. Acta Histochem Cytochem 26:619-622
47. Shibata N, Hirano A, Kobayashi M, Siddique T, Deng H-X, Hung W-Y, Kato T, Asayama K (1996) Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 55:481-490
48. Siddique T, Nijhawan D, Hentati A (1997) Familial amyotrophic lateral sclerosis. J Neural Transm 49 [Suppl]:219-233
49. Slälander A, Beckman G, Deng H-X, Iqbal Z, Tainer JA, Siddique T (1995) The D90A mutation results in a polymorphism of Cu, Zn superoxide dismutase that is prevalent in Northern Sweden and Finland. Hum Mol Genet 4:1105-1108
50. Smith MA, Taneda S, Richey PL, Miyata S, Yan S-D, Stern D, Sayre LM, Monnier VM, Perry G (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91:5710-5714
51. Takahashi H (1995) Familial amyotrophic lateral sclerosis with or without mutation of the Cu/Zn superoxide dismutase gene. Brain Nerve (Tokyo) 47:535-541
52. Takeda A, Yasuda T, Miyata T, Goto Y, Wakai M, Watanabe M, Yasuda Y, Horie K, Inagaki T, Doyu M, Maeda K, Sobue G (1998) Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease. Acta Neuropathol 95:555-558
53. Takizawa N, Takada K, Ohkawa K (1993) Inhibitory effect of nonenzymatic glycosylation on ubiquitination and ubiquitin-mediated degradation of lysozyme. Biochem Biophys Res Commun 192:700-706
54. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91:4766-4770
55. Vlassara H, Bucala R, Striker L (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implication for diabetes and aging. Lab Invest 70:138-151
56. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, Valentine JS, Bredesen DE (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271:515-518
57. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14:1105-1116
58. Yan SD, Chen X, Schmidt A-M, Brett J, Godman G, Zou Y-S, Scott CW, Caputo C, Frappier T, Smith MA, Perry G, Yen S-H, Stem D (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 91:7787-7791
59. Yan SD, Zhu H, Fu J, Yan SF, Roher A, Tourtellotte WW, Rajavashisth T, Chen X, Godman GC, Stern D, Schmidt AM (1997) Amyloid-β peptide - receptor for advanced glycation endproduct stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci USA 94:5296-5301